ArticleSleep & breathing = Schlaf & Atmung2025
The prevalence of high risk of obstructive sleep apnea in patients with psoriasis.
Article in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine the prevalence of high-risk OSA among people diagnosed with psoriasis and to investigate relationships between the risk of OSA and the characteristics of psoriasis.
methodsThis cross-sectional study was conducted after the approval of the review board during February 2023 and February 2024. Inclusion criteria were psoriasis patients aged ≥ 18 years who visited the dermatologic clinic, Siriraj Hospital, Thailand. Demographic data, anthropometric measurements, underlying conditions, types of psoriasis, Psoriasis Area and Severity Index scores, disease duration, percentage of body surface area involvement, Epworth Sleepiness Scale (ESS), and STOP-Bang questionnaire were collected. Patients who were unable to answer these questionnaires were excluded.
resultsOf the 200 participants (106 men, 94 women), 108 patients (54%) were identified as high-risk for OSA; of them, 70 were men (64.8%) and 38 were women (35.2%). Within this group, statistically significant differences were observed in male (p < 0.001), age (p = 0.02), and the presence of hypertension, diabetes, and dyslipidemia. Both BMI and an ESS score > 10 were also significantly elevated in the high-risk group (p < 0.05). However, no significant correlations were detected between various characteristics of psoriasis and the risk of OSA. Only male sex [adjusted odd ratios (OR) = 3.51], HT (OR = 2.87), and an ESS score > 10 (OR = 4.13), showed statistically significant associations with an increased risk of OSA (p < 0.05).
conclusionPsoriasis patients had a higher prevalence of high-risk OSA compared to the general Thai population. This underscores the importance of screening individuals with psoriasis, particularly those exhibiting concurrent HT, male sex, and EDS, for OSA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.